Biceltis (440 mg Single Dose.)

EMCURE Pharmaceutical Ltd

“Biceltis” contains Drug / Molecule called “Trastuzumab”. Trastuzumab is a type of immunotherapy known as a monoclonal antibody. It works by targeting certain tumour cells and stopping them from growing and reproducing. These antibodies interferes with the HER2/neu receptor protein that are embedded in the cell membrane and communicate molecular signals from outside the cell (molecules called EGFs) to inside the cell, and turn genes on and off.

Indication

Biceltis is used for the treatment of Metastatic Breast Cancer.

Note

Precaution

Biceltis is a prescription drug and should be used under proper medical guidance and advice.